Axsome Therapeutics Inc (GB:0HKF)
LSE:0HKF

Axsome Therapeutics (0HKF) Technical Analysis

1 Followers

Summary of all the Indicators

Summary
Neutral
9Bullish
4Neutral
9Bearish
Oscillators
Buy
4Bullish
4Neutral
2Bearish
Moving Averages
Sell
5Bullish
0Neutral
7Bearish
Axsome Therapeutics Inc’s (0HKF) Moving Averages Convergence Divergence (MACD) indicator is 0.55, suggesting Axsome Therapeutics Inc is a Buy.
Axsome Therapeutics Inc’s (0HKF) 20-Day exponential moving average is 72.79, while Axsome Therapeutics Inc’s (0HKF) share price is $69.984, making it a Sell.
Axsome Therapeutics Inc’s (0HKF) 50-Day exponential moving average is 70.24, while Axsome Therapeutics Inc’s (0HKF) share price is $69.984, making it a Sell.

Axsome Therapeutics (0HKF) Pivot Points

May 28, 2023, 05:31 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
66.12
66.71
67.01
67.61
67.91
68.50
68.80
Fibonacci
66.71
67.05
67.27
67.61
67.95
68.16
68.50

Axsome Therapeutics (0HKF) Moving Averages

May 28, 2023, 05:31 AM
Period
Simple
Exponential
MA5
70.88Sell
70.85Sell
MA10
74.07Sell
72.56Sell
MA20
74.08Sell
72.79Sell
MA50
68.45Buy
70.24Sell
MA100
67.26Buy
67.24Buy
MA200
62.69Buy
60.10Buy
Axsome Therapeutics Inc’s (0HKF) 10-Day exponential moving average is 72.56, while Axsome Therapeutics Inc’s (0HKF) share price is $69.984, making it a Sell.
Axsome Therapeutics Inc’s (0HKF) 100-Day exponential moving average is 67.24, while Axsome Therapeutics Inc’s (0HKF) share price is $69.984, making it a Buy.
Axsome Therapeutics Inc’s (0HKF) stock price is $69.984 and Axsome Therapeutics Inc’s (0HKF) 50-day simple moving average is 68.45, creating a Buy signal.
Axsome Therapeutics Inc’s (0HKF) stock price is $69.984 and Axsome Therapeutics Inc’s (0HKF) 100-day simple moving average is 67.26, creating a Buy signal.
Axsome Therapeutics Inc’s (0HKF) stock price is $69.984 and Axsome Therapeutics Inc’s (0HKF) 200-day simple moving average is 62.69, creating a Buy signal.

Axsome Therapeutics (0HKF) Technical Indicators

May 28, 2023, 05:31 AM
Name
Value
Action
RSI (14)
45.08
Neutral
STOCH (9,6)
7.62
Buy
STOCHRSI (14)
6.66
Buy
MACD (12,26)
0.55
Buy
ADX (14)
22.97
Neutral
Williams %R
-80.03
Buy
CCI (14)
-79.46
Neutral
ATR (14)
2.21
-
Ultimate Oscillator
40.59
Neutral
ROC
-4.03
Sell
Axsome Therapeutics Inc’s (0HKF) Relative Strength Index (RSI) is 45.08, creating a Neutral signal.
Axsome Therapeutics Inc’s (0HKF) Trend Strength Indicator (ADX) is 22.97, creating a Neutral signal.
Axsome Therapeutics Inc’s (0HKF) Commodity Channel Index (CCI) is -79.46, creating a Neutral signal.
Axsome Therapeutics Inc’s (0HKF) Price Rate of Change (ROC) is -4.03, creating a Sell signal.

FAQ

Is 0HKF a Buy, Hold, or Sell?
Based on 0HKF’s technical indicators, 0HKF is a Hold.
    What is 0HKF’s RSI (14)?
    0HKF’s RSI (14) is 45.08, which suggests 0HKF is a Neutral.
      What is 0HKF’s MACD?
      0HKF’s MACD is 0.55, which suggests 0HKF is a Buy.
        What is 0HKF’s 5-day moving average?
        0HKF’s 5-day moving average is 70.88, which suggests 0HKF is a Sell.
          What is 0HKF’s 20-day moving average?
          0HKF 20-day moving average is 74.08, which suggests 0HKF is a Sell.
            What is 0HKF’s 50-day moving average?
            0HKF’s 50-day moving average is 68.45, which suggests 0HKF is a Buy.
              What is 0HKF’s 200-day moving average?
              0HKF’s 200-day moving average is 62.69, which suggests 0HKF is a Buy.
                What is 0HKF’s Williams % R (14)?
                0HKF’s Williams % R (14) is -80.03, which suggests 0HKF is a Buy.
                  What is 0HKF’s CCI (14)?
                  0HKF’s CCI (14) is -79.46, which suggests 0HKF is a Neutral.

                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis